{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:38:14Z","timestamp":1771648694556,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00702-010-0546-9","type":"journal-article","created":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T14:53:57Z","timestamp":1294498437000},"page":"925-943","source":"Crossref","is-referenced-by-count":39,"title":["Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm"],"prefix":"10.1007","volume":"118","author":[{"given":"Bettina","family":"Wabbels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang H.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Roggenk\u00e4mper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,9]]},"reference":[{"issue":"Pt 1","key":"546_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/117.1.27","volume":"117","author":"M Aramideh","year":"1994","unstructured":"Aramideh M, Ongerboer de Visser BW, Devriese PP, Bour LJ, Speelman JD (1994) Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 117(Pt 1):27\u201338","journal-title":"Brain"},{"key":"546_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IOP.0b013e31819946c4","volume":"25","author":"MH Boyle","year":"2009","unstructured":"Boyle MH, McGwin G Jr, Flanagan CE, Vicinanzo MG, Long JA (2009) High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference? Ophthal Plast Reconstr Surg 25:81\u201384","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"546_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","volume":"347","author":"A Brashear","year":"2002","unstructured":"Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C (2002) Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 347:395\u2013400","journal-title":"N Engl J Med"},{"key":"546_CR4","first-page":"429","volume-title":"Therapy with botulinum toxin","author":"M Brin","year":"1994","unstructured":"Brin M, Blitzer A, Herman S, Steward C (1994) Oromandibular dystonia: treatment of 96 cases with botulinum A. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York, pp 429\u2013435"},{"key":"546_CR5","first-page":"183","volume-title":"Treatment of movement disorders","author":"MF Brin","year":"1995","unstructured":"Brin MF, Jankovic J, Comella C, Blitzer A, Tsui JKC, Pullman SL (1995) Treatment of dystonia using botulinum toxin. In: Kurlan R (ed) Treatment of movement disorders. Lippincott Company, New York, pp 183\u2013246"},{"key":"546_CR6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00417-008-0877-5","volume":"246","author":"G Casse","year":"2008","unstructured":"Casse G, Adenis JP, Sauvage JP, Robert PY (2008) Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection. Graefes Arch Clin Exp Ophthalmol 246:1307\u20131314","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"546_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/01676830802541004","volume":"28","author":"G Casse","year":"2009","unstructured":"Casse G, Adenis JP, Sauvage JP, Robert PY (2009) Videonystagmography to assess eyelid dynamic disorders. Orbit 28:20\u201324","journal-title":"Orbit"},{"key":"546_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002826-198610000-00002","volume":"9","author":"DA Cohen","year":"1986","unstructured":"Cohen DA, Savino PJ, Stern MB, Hurtig HI (1986) Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol 9:415\u2013429","journal-title":"Clin Neuropharmacol"},{"key":"546_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00839203","volume":"239","author":"JS Elston","year":"1992","unstructured":"Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239:5\u20138","journal-title":"J Neurol"},{"key":"546_CR10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/bmj.290.6485.1857","volume":"290","author":"JS Elston","year":"1985","unstructured":"Elston JS, Russell RW (1985) Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 290:1857\u20131859","journal-title":"Br Med J (Clin Res Ed)"},{"key":"546_CR11","first-page":"97","volume-title":"Blepharopsasm, advanced ophthalmology plastic reconstructive surgery","author":"S Fahn","year":"1985","unstructured":"Fahn S (1985) Rating scales for blepharopsasm. In: Bosniak SL (ed) Blepharopsasm, advanced ophthalmology plastic reconstructive surgery. Pergamom Press, New York, pp 97\u2013101"},{"issue":"(Suppl 1)","key":"546_CR12","first-page":"271","volume":"35","author":"S Fahn","year":"1985","unstructured":"Fahn S, List T, Moskowitz C, Brin M, Bressman S, Burke RE, Scott A (1985) Double-blind controlled study of botulinum toxin for blepharospasm. Neurology 35(Suppl 1):271\u2013272","journal-title":"Neurology"},{"key":"546_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(14)76386-X","volume":"106","author":"BR Frueh","year":"1988","unstructured":"Frueh BR, Nelson CC, Kapustiak JF, Musch DC (1988) The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment. Am J Ophthalmol 106:45\u201347","journal-title":"Am J Ophthalmol"},{"key":"546_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.870110107","volume":"11","author":"P Girlanda","year":"1996","unstructured":"Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C (1996) Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 11:27\u201331","journal-title":"Mov Disord"},{"key":"546_CR15","first-page":"S77","volume":"113","author":"S Goertelmeyer","year":"2002","unstructured":"Goertelmeyer S, Brinkmann G, Comes A, Delcker A (2002) The Blepharospasm Disability Index (BSDI) for the assessment of functional health in focal dystonia. Clin Neurophysiol 113:S77\u2013S78","journal-title":"Clin Neurophysiol"},{"key":"546_CR16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N, Marsden CD (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51:767\u2013772","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"546_CR17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.WNL.0000027361.73814.0E","volume":"59","author":"M Hallett","year":"2002","unstructured":"Hallett M (2002) Blepharospasm: recent advances. Neurology 59:1306\u20131312","journal-title":"Neurology"},{"key":"546_CR18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","volume":"37","author":"J Jankovic","year":"1987","unstructured":"Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37:616\u2013623","journal-title":"Neurology"},{"key":"546_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.22368","volume":"24","author":"J Jankovic","year":"2009","unstructured":"Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G (2009) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24:407\u2013413","journal-title":"Mov Disord"},{"key":"546_CR20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.870100407","volume":"10","author":"R Lindeboom","year":"1995","unstructured":"Lindeboom R, De Haan R, Aramideh M, Speelman JD (1995) The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 10:444\u2013449","journal-title":"Mov Disord"},{"key":"546_CR21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bjo.80.12.1073","volume":"80","author":"JA Mauriello Jr","year":"1996","unstructured":"Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC (1996) Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11\u00a0years. Br J Ophthalmol 80:1073\u20131076","journal-title":"Br J Ophthalmol"},{"key":"546_CR22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1531-8257(199911)14:6<1017::AID-MDS1018>3.0.CO;2-3","volume":"14","author":"T Mezaki","year":"1999","unstructured":"Mezaki T, Kaji R, Brin MF, Hirota-Katayama M, Kubori T, Shimizu T, Kimura J (1999) Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial. Mov Disord 14:1017\u20131020","journal-title":"Mov Disord"},{"key":"546_CR23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.2003.013441","volume":"75","author":"J M\u00fcller","year":"2004","unstructured":"M\u00fcller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A, Wenning GK, Poewe W (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75:749\u2013753","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"546_CR24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","volume":"323","author":"M Naumann","year":"2001","unstructured":"Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 323:596\u2013599","journal-title":"BMJ"},{"key":"546_CR25","first-page":"363","volume":"4","author":"Z Nussgens","year":"1995","unstructured":"Nussgens Z, Roggenkamper P (1995) Long-term treatment of blepharospasm with botulinum toxin type A. Ger J Ophthalmol 4:363\u2013367","journal-title":"Ger J Ophthalmol"},{"key":"546_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","volume":"235","author":"Z Nussgens","year":"1997","unstructured":"Nussgens Z, Roggenk\u00e4mper P (1997) Comparison of two botulinum toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197\u2013199","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"546_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","volume":"104","author":"J Price","year":"1997","unstructured":"Price J, Farish S, Taylor H, O\u2019Day J (1997) Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology 104:865\u2013868","journal-title":"Ophthalmology"},{"key":"546_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/WNF.0b013e3181c46f61","volume":"33","author":"EM Quagliato","year":"2010","unstructured":"Quagliato EM, Carelli EF, Viana MA (2010) Prospective, randomized, double-blind study, comparing botulinum toxins type A Botox and Prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 33:27\u201331","journal-title":"Clin Neuropharmacol"},{"key":"546_CR29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.eye.6700444","volume":"17","author":"R Rahman","year":"2003","unstructured":"Rahman R, Berry-Brincat A, Thaller VT (2003) A new grading system for assessing orbicularis muscle function. Eye 17:610\u2013612","journal-title":"Eye"},{"key":"546_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.WNF.0000236771.77021.3C","volume":"30","author":"CR Rieder","year":"2007","unstructured":"Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD (2007) A double-blind, randomized, crossover study of Prosigne versus Botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30:39\u201342","journal-title":"Clin Neuropharmacol"},{"key":"546_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K, Comes G, Grafe S (2006) Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303\u2013312","journal-title":"J Neural Transm"},{"key":"546_CR32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"C Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1. Mov Disord 12:1013\u20131018","journal-title":"Mov Disord"},{"key":"546_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","volume":"103","author":"AB Scott","year":"1985","unstructured":"Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103:347\u2013350","journal-title":"Arch Ophthalmol"},{"key":"546_CR34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","volume":"46","author":"DM Simpson","year":"1996","unstructured":"Simpson DM, Alexander DN, O\u2019Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 46:1306\u20131310","journal-title":"Neurology"},{"key":"546_CR35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","volume":"14","author":"D Truong","year":"2008","unstructured":"Truong D, Comella C, Fernandez HH, Ondo WG (2008) Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat Disord 14:407\u2013414","journal-title":"Parkinsonism Relat Disord"},{"key":"546_CR36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0002-9394(85)90228-4","volume":"99","author":"EA Tsoy","year":"1985","unstructured":"Tsoy EA, Buckley EG, Dutton JJ (1985) Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol 99:176\u2013179","journal-title":"Am J Ophthalmol"},{"key":"546_CR37","unstructured":"Wabbels B, Reichel G, Fulford-Smith A, Wright N, Roggenk\u00e4mper P (2010) Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. J Neural Transm. [Epub ahead of print] PMID:21161715"},{"key":"546_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","volume":"20","author":"J Wissel","year":"2000","unstructured":"Wissel J, Muller J, Dressnandt J, Heinen F, Naumann M, Topka H, Poewe W (2000) Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manag 20:44\u201349","journal-title":"J Pain Symptom Manag"},{"key":"546_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3341\/kjo.2009.23.3.137","volume":"23","author":"JS Yoon","year":"2009","unstructured":"Yoon JS, Kim JC, Lee SY (2009) Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. Korean J Ophthalmol 23:137\u2013141","journal-title":"Korean J Ophthalmol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00702-010-0546-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:28:01Z","timestamp":1637119681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0546-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,9]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0546-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,9]]}}}